To further verify whether cell sensitivity to FAK or Src inhibitors was associated with COL4A1 expression, we examined cell sensitivity to those two inhibitors after modulating COL4A1 expression in HCC cells. The gene discussed is COL4A1; the disease is hepatocellular carcinoma.